Item Details

Race-Based Therapeutics [videorecording]

[presented by] the University of Virginia Medical School
Format
Video; DVD; Online
Summary
Ruth Gaare Bernheim, J.D., M.P.H. (Associate Professor of Public Health Sciences; Director, Division of Public Health Policy and Practice, Department of Public Health Sciences and Associate Director, Institute for Practical Ethics, University of Virginia) introduced the new masters program in public health at the University of Virginia and the first speaker. M. Gregg Bloche, J.D., M.D. (Professor of Law, Georgetown University School of Law and Visiting Professor of Law, UCLA) described a frame work for describing medical advances with technological change driven by basic and clinical reseach along with economic factors and the marketing of health and health care in terms of race. Dr. Bloche illustrated this framework with the FDA approved BiDil used to treat heart failure in self-identified black patients and Pfizer's Torcetrapib used to combat heart disease by raising HDL. Other topics concerning intellectual property, "funding orphan research," and "ethical norms for academic medicine" were discussed. M. Norman Oliver, M.D. (Associate Professor of Family Medicine, Public Health Sciences, and Anthropology; Associate Dean for Diversity, and Director, Center on Health Disparities, University of Virginia School of Medicine) presented a "prohibitive" view of using skin color for targeting therapeutic research and health care and proposed the use of geographical or ancestral variation as a means of targeting a group of people for research and health care.
Performers
Panelists: Ruth Gaare Bernheim, M. Gregg Bloche, M. Norman Oliver; Moderator, Marcia Day Childress
Release Date
2007
Run Time
60 min.
Language
English
Notes
  • "Co-presented with the Department of Public Health Sciences, the Institute for Practical Ethics and the Center on Health Disparities, UVA." -- from program flyer
  • Learning Objectives: 1. Appreciate new developments in medical therapeutics based on biologic variations in human subpopulations -- 2. Consider the benefits and risks of thinking about disease and treatment using racial categories.
  • The Medical Center Hour is produced by The Center for Humanism in Medicine, University of Virginia School of Medicine. The Medical Center Hour's website is: http://www.healthsystem.virginia.edu/internet/him/mch.cfm.
  • "Medicine & Society in Conversation."
Series
Medical Center Hour
Series Statement
Medical center hour ; 1/24/07
Published
Charlottesville, Va. : The University, [Clinical Engineering, Media Production Services], c2007.
Related Resources
ACCESS TO GENERAL INFORMATION AND UPCOMING SCHEDULE ONLY
Description
1 videodisc (60 min.) sd., col. ; 4 3/4 in. + script.
DVD.
Technical Details
  • Access in Virgo Classic

  • LEADER 04205ngm a2200541Ia 4500
    001 u4471158
    003 SIRSI
    005 20070301105912.0
    007 vd cgaiz|
    008 070301s2007 vau060 f s vleng d
    035
      
      
    a| (OCoLC)85480773
    040
      
      
    a| VAM c| VAM
    049
      
      
    a| VAMB c| 1 a| VAMH c| 2
    090
      
      
    a| R11 b| .M4 1/24/2007
    245
    0
    0
    a| Race-based therapeutics h| [videorecording] / c| [presented by] the University of Virginia Medical School.
    260
      
      
    a| Charlottesville, Va. : b| The University, [Clinical Engineering, Media Production Services], c| c2007.
    300
      
      
    a| 1 videodisc (60 min.) b| sd., col. ; c| 4 3/4 in. + e| script.
    440
      
    0
    a| Medical center hour ; v| 1/24/07
    500
      
      
    a| "Co-presented with the Department of Public Health Sciences, the Institute for Practical Ethics and the Center on Health Disparities, UVA." -- from program flyer
    500
      
      
    a| Learning Objectives: 1. Appreciate new developments in medical therapeutics based on biologic variations in human subpopulations -- 2. Consider the benefits and risks of thinking about disease and treatment using racial categories.
    500
      
      
    a| The Medical Center Hour is produced by The Center for Humanism in Medicine, University of Virginia School of Medicine. The Medical Center Hour's website is: http://www.healthsystem.virginia.edu/internet/him/mch.cfm.
    500
      
      
    a| "Medicine & Society in Conversation."
    511
      
      
    a| Panelists: Ruth Gaare Bernheim, M. Gregg Bloche, M. Norman Oliver; Moderator, Marcia Day Childress
    520
      
      
    a| Ruth Gaare Bernheim, J.D., M.P.H. (Associate Professor of Public Health Sciences; Director, Division of Public Health Policy and Practice, Department of Public Health Sciences and Associate Director, Institute for Practical Ethics, University of Virginia) introduced the new masters program in public health at the University of Virginia and the first speaker. M. Gregg Bloche, J.D., M.D. (Professor of Law, Georgetown University School of Law and Visiting Professor of Law, UCLA) described a frame work for describing medical advances with technological change driven by basic and clinical reseach along with economic factors and the marketing of health and health care in terms of race. Dr. Bloche illustrated this framework with the FDA approved BiDil used to treat heart failure in self-identified black patients and Pfizer's Torcetrapib used to combat heart disease by raising HDL. Other topics concerning intellectual property, "funding orphan research," and "ethical norms for academic medicine" were discussed. M. Norman Oliver, M.D. (Associate Professor of Family Medicine, Public Health Sciences, and Anthropology; Associate Dean for Diversity, and Director, Center on Health Disparities, University of Virginia School of Medicine) presented a "prohibitive" view of using skin color for targeting therapeutic research and health care and proposed the use of geographical or ancestral variation as a means of targeting a group of people for research and health care.
    530
      
      
    a| Also available via webcast, download, or podcast as viewed 3/27/2007.
    538
      
      
    a| DVD.
    596
      
      
    a| 19
    650
      
    2
    a| Continental Population Groups z| United States
    650
      
    2
    a| Genetic Research x| ethics z| United States
    650
      
    2
    a| Hydralazine x| therapeutic use
    650
      
    2
    a| Isosorbide Dinitrate x| therapeutic use
    650
      
    2
    a| Quinolines x| therapeutic use
    650
      
    2
    a| Heart Failure x| drug therapy
    650
      
    2
    a| Therapeutics x| ethics z| United States
    650
      
    2
    a| Bioethics z| United States
    650
      
    2
    a| Intellectual Property z| United States
    655
      
    7
    a| Podcasts 2| Local
    700
    1
      
    a| Bernheim, Ruth Gaare.
    700
    1
      
    a| Bloche, Maxwell Gregg.
    700
    1
      
    a| Oliver, M. Norman.
    700
    1
      
    a| Childress, Marcia Day.
    710
    2
      
    a| University of Virginia. b| School of Medicine.
    856
    4
    1
    u| http://www.virginia.edu/uvapodcast/popup.php?submit=true&id=395
    856
    4
    2
    3| ACCESS TO GENERAL INFORMATION AND UPCOMING SCHEDULE ONLY u| http://www.healthsystem.virginia.edu/internet/him/
    994
      
      
    a| C0 b| VAM
    999
      
      
    a| R11 .M4 1/24/2007 w| HS-LC i| 3470362365 l| RARESHL m| HEALTHSCI t| RAREAV
    999
      
      
    a| R11 .M4 1/24/2007 w| HS-LC i| 3470362366 l| SERV-DSK m| HEALTHSCI t| HS-VDVD

Availability

Google Preview

Watch Online

Library Location Map Availability Call Number
Health Sciences Service Desk N/A Available
Health Sciences Rare Shelves N/A Available Non-Circ.